{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:04:08Z","timestamp":1789632248086,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.pdpdt.2026.105359","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:27:38Z","timestamp":1769128058000},"page":"105359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Randomized comparative study of 5-Fluorouracil 4%, tirbanibulin, and photodynamic therapy for relapsing actinic keratoses"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5053-4172","authenticated-orcid":false,"given":"Federico","family":"Venturi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Magnaterra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gualandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Baraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Alessandrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Vaccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Dika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pdpdt.2026.105359_bib0001","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40257-023-00839-8","article-title":"Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review","volume":"25","author":"Aggarwal","year":"2024","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.pdpdt.2026.105359_bib0002","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jaad.2020.03.126","article-title":"Field cancerization: Definition, epidemiology, risk factors, and outcomes","volume":"83","author":"Willenbrink","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.pdpdt.2026.105359_bib0003","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jdv.14151","article-title":"From actinic keratosis to squamous cell carcinoma: pathophysiology revisited","volume":"31","author":"Fernandez Figueras","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 5","key":"10.1016\/j.pdpdt.2026.105359_bib0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jdv.19559","article-title":"Actinic keratosis: Current challenges and unanswered questions","volume":"38","author":"Malvehy","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 2","key":"10.1016\/j.pdpdt.2026.105359_bib0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jdv.14092","article-title":"The importance of treating the field in actinic keratosis","volume":"31","author":"Stockfleth","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.pdpdt.2026.105359_bib0006","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jid.2020.09.002","article-title":"Actinic Keratoses: Reconciling the Biology of Field Cancerization with Treatment Paradigms","volume":"141","author":"Gilchrest","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.pdpdt.2026.105359_bib0007","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/jdv.14652","article-title":"Defining the actinic keratosis field: a literature review and discussion","volume":"32","author":"Figueras Nart","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.pdpdt.2026.105359_bib0008","first-page":"628","article-title":"Risk of skin cancer development in 672 patients affected by actinic keratosis","volume":"151","author":"Dika","year":"2016","journal-title":"G Ital Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.pdpdt.2026.105359_bib0009","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14607","article-title":"Field cancerization in clinically solitary actinic keratosis: A pilot study","volume":"34","author":"Micali","year":"2021","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.pdpdt.2026.105359_bib0010","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40257-018-0348-7","article-title":"Field Cancerization Therapies for Management of Actinic Keratosis: A Narrative Review","volume":"19","author":"Jetter","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.pdpdt.2026.105359_bib0011","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jamadermatol.2024.5750","article-title":"Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention","volume":"161","author":"Cox","year":"2025","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.pdpdt.2026.105359_bib0012","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/ced.15215","article-title":"Cutaneous immune-related adverse events and photodamaged skin in patients with metastatic melanoma: could nicotinamide be useful?","volume":"47","author":"De Giorgi","year":"2022","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"10.1016\/j.pdpdt.2026.105359_bib0013","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/jdv.13648","article-title":"Italian expert consensus for the management of actinic keratosis in immunocompetent patients","volume":"30","author":"Peris","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.pdpdt.2026.105359_bib0014","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1016\/j.jaad.2021.02.082","article-title":"Guidelines of care for the management of actinic keratosis","volume":"85","author":"Eisen","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.pdpdt.2026.105359_bib0015","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1056\/NEJMoa1811850","article-title":"Randomized Trial of Four Treatment Approaches for Actinic Keratosis","volume":"380","author":"Jansen","year":"2019","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.pdpdt.2026.105359_bib0016","article-title":"Interventions for actinic keratoses","volume":"12","author":"Gupta","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.pdpdt.2026.105359_bib0017","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.3390\/ijms24054989","article-title":"Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review","volume":"24","author":"Arcuri","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.pdpdt.2026.105359_bib0018","first-page":"413","article-title":"Pain evaluation in patients affected by cutaneous squamous cell carcinoma and actinic keratosis: an observational study","volume":"152","author":"Dika","year":"2017","journal-title":"G Ital Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.pdpdt.2026.105359_bib0019","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3390\/ph16121686","article-title":"Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses","volume":"16","author":"Campione","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.pdpdt.2026.105359_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2024.104235","article-title":"Reflectance confocal microscopy as noninvasive tool for monitoring tirbanibulin efficacy in actinic keratosis","volume":"48","author":"Venturi","year":"2024","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"3","key":"10.1016\/j.pdpdt.2026.105359_bib0021","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.5826\/dpc.1503a5921","article-title":"Real-World Efficacy of Tirbanibulin in Actinic Keratosis Treatment: Expert Consensus and Clinical Insights","volume":"15","author":"Ardig\u00f2","year":"2025","journal-title":"Dermatol Pract Concept"},{"issue":"2","key":"10.1016\/j.pdpdt.2026.105359_bib0022","first-page":"98","article-title":"Folliculotropism in Actinic Keratoses in Patients not Responding to Treatments: A Pilot Study","volume":"31","author":"Dika","year":"2023","journal-title":"Acta Dermatovenerol Croat"},{"issue":"2","key":"10.1016\/j.pdpdt.2026.105359_bib0023","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/DSS.0000000000003677","article-title":"Field Therapy for Actinic Keratosis: A Structured Review of the Literature on Efficacy, Cost, and Adherence","volume":"49","author":"Lampley","year":"2023","journal-title":"Dermatol Surg"},{"issue":"8","key":"10.1016\/j.pdpdt.2026.105359_bib0024","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/jdv.14267","article-title":"A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index","volume":"31","author":"Dirschka","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.pdpdt.2026.105359_bib0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/biomedicines6010008","article-title":"Actinic Keratosis and Non-Invasive Diagnostic Techniques: An Update","volume":"6","author":"Casari","year":"2018","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.pdpdt.2026.105359_bib0026","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/jdv.13215","article-title":"Grading keratinocyte atypia in actinic keratosis: a correlation of reflectance confocal microscopy and histopathology","volume":"29","author":"Pellacani","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.pdpdt.2026.105359_bib0027","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/jdv.15091","article-title":"Reflectance confocal microscopy: a crucial role for actinic keratosis treatment monitoring","volume":"32","author":"Pellacani","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.pdpdt.2026.105359_bib0028","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13555-014-0059-9","article-title":"A new, objective, quantitative scale for measuring local skin responses following topical actinic keratosis therapy with ingenol mebutate","volume":"4","author":"Rosen","year":"2014","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100026000268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100026000268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:21:21Z","timestamp":1789629681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100026000268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":28,"alternative-id":["S1572100026000268"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105359","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized comparative study of 5-Fluorouracil 4%, tirbanibulin, and photodynamic therapy for relapsing actinic keratoses","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105359"}}